Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Lapatinib in Metastatic Bladder Cancer
NCT01382706Phase 2Terminated
- Sponsor
- University of Southern California
- Start
- Jun 2011
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in bladder cancer, sponsored by University of Southern California. Started Jun 2011; status: terminated.
02
Drugs
lapatinib
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT01382706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01382706.